Covered recipient · General Payments record
RICARDO OMAR CALONGE
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$23,615.51
- Reported across 303 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $819.16 | 31 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $339.20 | 13 |
| PFIZER INC. | $166.33 | 8 |
| ABBVIE INC. | $148.84 | 3 |
| Novo Nordisk AS | $69.95 | 3 |
| Edwards Lifesciences Corporation | $32.54 | 1 |
| GlaxoSmithKline, LLC. | $26.81 | 1 |
| DEXCOM, INC. | $18.62 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $16.87 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (31)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $31.57 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103406685 | CMS |
| ABBVIE INC. | $104.17 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103406687 | CMS |
| ABBVIE INC. | $13.10 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103406689 | CMS |
| Dexcom, Inc. | $18.62 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153330573 | CMS |
| Edwards Lifesciences Corporation | $32.54 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138865711 | CMS |
| GlaxoSmithKline, LLC. | $26.81 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116676067 | CMS |
| Lilly USA, LLC | $19.95 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135363857 | CMS |
| Lilly USA, LLC | $16.32 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135384383 | CMS |
| Lilly USA, LLC | $19.06 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135356829 | CMS |
| Lilly USA, LLC | $17.80 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135374710 | CMS |
| Lilly USA, LLC | $18.00 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135386203 | CMS |
| Lilly USA, LLC | $26.51 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135365196 | CMS |
| Lilly USA, LLC | $14.23 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135365194 | CMS |
| Lilly USA, LLC | $14.16 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135363859 | CMS |
| Lilly USA, LLC | $15.86 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135353268 | CMS |
| Lilly USA, LLC | $15.25 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135363861 | CMS |
| Lilly USA, LLC | $14.75 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135333951 | CMS |
| Lilly USA, LLC | $25.44 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135386201 | CMS |
| Lilly USA, LLC | $121.87 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135374708 | CMS |
| Novartis Pharmaceuticals Corporation | $16.87 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086715197 | CMS |
| Novo Nordisk Inc | $19.75 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097788443 | CMS |
| Novo Nordisk Inc | $21.15 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096787332 | CMS |
| Novo Nordisk Inc | $29.05 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096699396 | CMS |
| PFIZER INC. | $22.04 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132018706 | CMS |
| PFIZER INC. | $25.52 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131050411 | CMS |
| PFIZER INC. | $5.92 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131921581 | CMS |
| PFIZER INC. | $21.72 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131476623 | CMS |
| PFIZER INC. | $21.76 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131470494 | CMS |
| PFIZER INC. | $24.62 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131746170 | CMS |
| PFIZER INC. | $21.09 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131995295 | CMS |
| PFIZER INC. | $23.66 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131975911 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.